发明申请
US20080026088A1 Reduced isoalpha acid based protein kinase modulation cancer treatment
审中-公开
减少基于isoalpha酸的蛋白激酶调制癌症治疗
- 专利标题： Reduced isoalpha acid based protein kinase modulation cancer treatment
- 专利标题（中）： 减少基于isoalpha酸的蛋白激酶调制癌症治疗
-
申请号： US11820653申请日： 2007-06-20
-
公开(公告)号： US20080026088A1公开(公告)日： 2008-01-31
- 发明人: Matthew Tripp , John Babish , Jeffrey Bland , Veera Konda , Amy Hall , Linda Pacioretty , Anu Desai
- 申请人： Matthew Tripp , John Babish , Jeffrey Bland , Veera Konda , Amy Hall , Linda Pacioretty , Anu Desai
- 申请人地址： US CA San Clemente
- 专利权人： Metaproteomics, LLC
- 当前专利权人： Metaproteomics, LLC
- 当前专利权人地址： US CA San Clemente
- 主分类号： A61K36/18
- IPC分类号： A61K36/18 ; A61P35/00
摘要：
Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on reduced isoalpha acids, commonly found in hops.
信息查询
